Stocktoria
Candel Therapeutics, Inc. CADL
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-07-27
Candel Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 1,060,086 | $5.2M |
| BlackRock Finance, Inc. | 823,071 | $5.1M |
| CITADEL ADVISORS LLC | 126,766 | $621,153 |
| Point72 Asset Management, L.P. | 107,211 | $525,334 |
| TWO SIGMA INVESTMENTS, LP | 93,500 | $458,150 |
| AQR CAPITAL MANAGEMENT LLC | 18,028 | $88,338 |
| RENAISSANCE TECHNOLOGIES LLC | 12,780 | $62,622 |
Source: SEC EDGAR filings · CIK 0001841387 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.